Biotechnology
The Biotechnology industry has a total of 639 stocks, with a combined market cap of $852.74 billion and total revenue of $97.87 billion.
Market Cap
852.74B
Revenue
97.87B
Profits
-44.71B
PE Ratio
n/a
Profit Margin
-45.68%
Dividend Yield
0.05%
639 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 120.83B | -1.88% | 460,198 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 59.67B | 0.88% | 369,809 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.36B | -1.69% | 478,514 | 2.35B |
| 4 | ARGX | argenx SE | 34.72B | -0.34% | 156,543 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 29.55B | -1.55% | 132,980 | 4.18B |
| 6 | BNTX | BioNTech SE | 27.74B | -1.11% | 271,491 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 20.16B | -0.73% | 622,257 | 2.26B |
| 8 | INSM | Insmed Incorporated | 18.87B | 2.75% | 1,377,603 | 381.03M |
| 9 | SMMT | Summit Therapeutics Inc. | 18.55B | -3.48% | 1,040,624 | - |
| 10 | INCY | Incyte Corporation | 13.45B | -1.25% | 371,416 | 4.41B |
| 11 | GMAB | Genmab A/S | 13.43B | -1.78% | 528,839 | 3.23B |
| 12 | MRNA | Moderna, Inc. | 12.93B | -2.48% | 4,327,652 | 3.18B |
| 13 | EXEL | Exelixis, Inc. | 12.35B | 0.27% | 582,141 | 2.30B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 11.13B | -1.31% | 823,398 | 2.95B |
| 15 | ASND | Ascendis Pharma A/S | 10.68B | -0.02% | 253,206 | 398.51M |
| 16 | VRNA | Verona Pharma plc | 9.56B | 0.01% | 8,680,736 | 118.54M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 8.81B | 0.32% | 685,670 | 127.42M |
| 18 | TECH | Bio-Techne Corporation | 8.46B | -0.86% | 361,905 | 1.21B |
| 19 | BPMC | Blueprint Medicines Corporation | 8.37B | -0.02% | 2,469,472 | 562.12M |
| 20 | ROIV | Roivant Sciences Ltd. | 7.74B | -1.56% | 1,705,636 | 29.05M |
| 21 | CORT | Corcept Therapeutics Incorporated | 7.62B | -0.26% | 219,417 | 685.45M |
| 22 | CAI | Caris Life Sciences, Inc. | 7.37B | -0.45% | 173,423 | 452.50M |
| 23 | LEGN | Legend Biotech Corporation | 7.19B | -1.79% | 329,362 | 728.30M |
| 24 | RVMD | Revolution Medicines, Inc. | 7.10B | -0.94% | 413,904 | - |
| 25 | HALO | Halozyme Therapeutics, Inc. | 7.07B | -0.50% | 424,544 | 1.08B |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 7.00B | 0.18% | 67,853 | 317.38M |
| 27 | JAZZ | Jazz Pharmaceuticals plc | 6.67B | -2.02% | 116,448 | 4.06B |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 6.62B | -1.91% | 451,844 | 717.25M |
| 29 | NUVL | Nuvalent, Inc. | 5.85B | -0.69% | 90,062 | - |
| 30 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.54B | -2.23% | 481,273 | 136.86M |
| 31 | TGTX | TG Therapeutics, Inc. | 5.46B | -0.53% | 423,893 | 386.39M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 5.41B | -0.98% | 571,541 | 432.16M |
| 33 | TLX | Telix Pharmaceuticals Limited | 5.35B | -2.17% | 8,997 | 484.69M |
| 34 | CRSP | CRISPR Therapeutics AG | 5.18B | -4.25% | 1,545,203 | 37.68M |
| 35 | PCVX | Vaxcyte, Inc. | 4.59B | -1.85% | 898,827 | - |
| 36 | CYTK | Cytokinetics, Incorporated | 4.39B | 0.52% | 393,690 | 19.22M |
| 37 | ADMA | ADMA Biologics, Inc. | 4.38B | -0.76% | 818,004 | 459.38M |
| 38 | KRYS | Krystal Biotech, Inc. | 4.29B | -0.76% | 120,714 | 333.45M |
| 39 | SLNO | Soleno Therapeutics, Inc. | 4.14B | 2.39% | 1,392,281 | - |
| 40 | AKRO | Akero Therapeutics, Inc. | 4.12B | -0.62% | 242,673 | - |
| 41 | MRUS | Merus N.V. | 4.06B | -0.98% | 132,556 | 54.73M |
| 42 | MTSR | Metsera, Inc. | 4.06B | 6.12% | 328,236 | - |
| 43 | RNA | Avidity Biosciences, Inc. | 3.84B | 1.33% | 2,388,592 | 8.93M |
| 44 | PTCT | PTC Therapeutics, Inc. | 3.84B | -2.10% | 232,456 | 1.77B |
| 45 | ACLX | Arcellx, Inc. | 3.77B | -0.67% | 65,761 | 76.81M |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | -2.77% | 859,355 | 996.28M |
| 47 | ZLAB | Zai Lab Limited | 3.59B | -4.81% | 377,509 | 418.33M |
| 48 | SRRK | Scholar Rock Holding Corporation | 3.54B | -2.14% | 211,692 | - |
| 49 | VKTX | Viking Therapeutics, Inc. | 3.47B | -1.25% | 1,472,939 | - |
| 50 | AAPG | Ascentage Pharma Group International | 3.34B | -5.54% | 4,067 | 134.35M |
| 51 | PTGX | Protagonist Therapeutics, Inc. | 3.29B | 0.56% | 254,977 | 207.80M |
| 52 | MLTX | MoonLake Immunotherapeutics | 3.12B | 0.45% | 274,333 | - |
| 53 | KYMR | Kymera Therapeutics, Inc. | 3.11B | -1.90% | 207,429 | 58.89M |
| 54 | IMVT | Immunovant, Inc. | 3.09B | 3.14% | 520,934 | - |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.99B | -0.25% | 249,320 | 760.00K |
| 56 | RARE | Ultragenyx Pharmaceutical Inc. | 2.80B | -4.37% | 2,808,595 | 590.69M |
| 57 | MIRM | Mirum Pharmaceuticals, Inc. | 2.65B | 0.96% | 151,739 | 379.25M |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.64B | -0.78% | 575,602 | 534.65M |
| 59 | IBRX | ImmunityBio, Inc. | 2.53B | - | 3,579,176 | 31.22M |
| 60 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.52B | -3.13% | 544,458 | 545.21M |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 2.48B | -1.85% | 231,039 | 7.50M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | -0.98% | 362,854 | 47.14M |
| 63 | APLS | Apellis Pharmaceuticals, Inc. | 2.43B | -0.97% | 283,196 | 775.84M |
| 64 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | -6.30% | 23,030,556 | 59.79M |
| 65 | AGIO | Agios Pharmaceuticals, Inc. | 2.26B | -1.26% | 324,280 | 37.04M |
| 66 | APGE | Apogee Therapeutics, Inc. | 2.26B | 0.34% | 387,099 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 2.12B | -5.02% | 837,550 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 2.06B | -4.27% | 1,376,157 | 63.58M |
| 69 | BLTE | Belite Bio, Inc | 2.04B | 0.90% | 161,594 | - |
| 70 | CGON | CG Oncology, Inc. | 2.03B | -1.55% | 146,277 | 662.00K |
| 71 | VCEL | Vericel Corporation | 2.03B | -2.35% | 103,828 | 238.54M |
| 72 | GLPG | Galapagos NV | 2.01B | -0.59% | 49,361 | 311.49M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 1.98B | -0.66% | 387,793 | 7.00M |
| 74 | IRON | Disc Medicine, Inc. | 1.98B | -1.66% | 141,768 | - |
| 75 | HRMY | Harmony Biosciences Holdings, Inc. | 1.95B | -0.87% | 135,862 | 744.85M |
| 76 | CNTA | Centessa Pharmaceuticals plc | 1.92B | -1.77% | 191,622 | 15.00M |
| 77 | FOLD | Amicus Therapeutics, Inc. | 1.89B | -2.78% | 1,031,872 | 543.14M |
| 78 | COGT | Cogent Biosciences, Inc. | 1.82B | 2.21% | 1,507,215 | - |
| 79 | ADPT | Adaptive Biotechnologies Corporation | 1.80B | -2.07% | 894,456 | 189.53M |
| 80 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | -4.75% | 1,667,949 | 2.23B |
| 81 | ARQT | Arcutis Biotherapeutics, Inc. | 1.78B | -2.10% | 557,854 | 212.82M |
| 82 | OCUL | Ocular Therapeutix, Inc. | 1.78B | 0.72% | 1,185,955 | 59.65M |
| 83 | SPRY | ARS Pharmaceuticals, Inc. | 1.76B | -0.06% | 372,052 | 97.12M |
| 84 | IMCR | Immunocore Holdings plc | 1.76B | -1.27% | 62,420 | 333.58M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 1.68B | -3.09% | 133,066 | 233.67M |
| 86 | ETNB | 89bio, Inc. | 1.61B | 2.50% | 389,514 | - |
| 87 | VERA | Vera Therapeutics, Inc. | 1.54B | -1.03% | 148,874 | - |
| 88 | CLDX | Celldex Therapeutics, Inc. | 1.52B | 0.97% | 403,105 | 7.56M |
| 89 | JANX | Janux Therapeutics, Inc. | 1.49B | -1.37% | 502,111 | 9.34M |
| 90 | TVTX | Travere Therapeutics, Inc. | 1.46B | -0.66% | 475,099 | 273.53M |
| 91 | EWTX | Edgewise Therapeutics, Inc. | 1.44B | -1.51% | 113,214 | - |
| 92 | BHVN | Biohaven Ltd. | 1.43B | -6.79% | 727,990 | - |
| 93 | VRDN | Viridian Therapeutics, Inc. | 1.39B | -0.64% | 157,800 | 302.00K |
| 94 | MESO | Mesoblast Limited | 1.39B | -1.36% | 61,135 | 5.67M |
| 95 | PROK | ProKidney Corp. | 1.35B | -11.20% | 14,184,827 | 306.00K |
| 96 | ELVN | Enliven Therapeutics, Inc. | 1.34B | -0.35% | 153,431 | - |
| 97 | CVAC | CureVac N.V. | 1.22B | -0.18% | 873,997 | 566.04M |
| 98 | DYN | Dyne Therapeutics, Inc. | 1.22B | -1.82% | 1,393,496 | - |
| 99 | WVE | Wave Life Sciences Ltd. | 1.22B | -0.25% | 571,829 | 104.94M |
| 100 | ABCL | AbCellera Biologics Inc. | 1.21B | -4.59% | 3,145,653 | 23.11M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.20B | -0.28% | 766,607 | 247.30M |
| 102 | INVA | Innoviva, Inc. | 1.20B | -0.05% | 361,819 | 369.84M |
| 103 | NTLA | Intellia Therapeutics, Inc. | 1.19B | -5.26% | 1,850,748 | 45.57M |
| 104 | PHVS | Pharvaris N.V. | 1.19B | 10.34% | 62,721 | - |
| 105 | LQDA | Liquidia Corporation | 1.19B | -1.70% | 456,768 | 14.14M |
| 106 | MNKD | MannKind Corporation | 1.14B | -1.05% | 702,259 | 297.60M |
| 107 | GPCR | Structure Therapeutics Inc. | 1.12B | 3.17% | 403,560 | - |
| 108 | NVAX | Novavax, Inc. | 1.11B | -3.24% | 2,353,982 | 1.25B |
| 109 | CDTX | Cidara Therapeutics, Inc. | 1.09B | -2.81% | 223,775 | 302.00K |
| 110 | ARDX | Ardelyx, Inc. | 1.08B | -3.83% | 3,100,117 | 361.71M |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 1.02B | -0.51% | 169,878 | 8.12M |
| 112 | ZYME | Zymeworks Inc. | 1.01B | -1.39% | 189,821 | 93.38M |
| 113 | OCS | Oculis Holding AG | 989.79M | -1.36% | 14,543 | 847.33K |
| 114 | RCUS | Arcus Biosciences, Inc. | 987.91M | -2.20% | 208,403 | 141.00M |
| 115 | VERV | Verve Therapeutics, Inc. | 987.44M | -0.05% | 1,366,798 | 59.61M |
| 116 | GHRS | GH Research PLC | 983.15M | -1.25% | 87,298 | - |
| 117 | LENZ | LENZ Therapeutics, Inc. | 981.17M | 1.75% | 331,370 | - |
| 118 | MDXG | MiMedx Group, Inc. | 977.79M | -2.36% | 251,124 | 352.38M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 964.79M | -0.39% | 506,575 | 88.38M |
| 120 | SYRE | Spyre Therapeutics, Inc. | 954.19M | -0.94% | 74,960 | - |
| 121 | MLYS | Mineralys Therapeutics, Inc. | 953.19M | -0.10% | 156,765 | - |
| 122 | SANA | Sana Biotechnology, Inc. | 951.84M | 3.94% | 3,041,732 | - |
| 123 | ORIC | ORIC Pharmaceuticals, Inc. | 951.10M | -2.53% | 211,584 | - |
| 124 | AVXL | Anavex Life Sciences Corp. | 948.48M | -0.63% | 314,352 | - |
| 125 | NAGE | Niagen Bioscience, Inc. | 903.43M | -2.93% | 364,926 | 107.93M |
| 126 | SION | Sionna Therapeutics, Inc. | 891.98M | -3.39% | 16,110 | - |
| 127 | REPL | Replimune Group, Inc. | 858.75M | 3.44% | 1,263,096 | - |
| 128 | CRMD | CorMedix Inc. | 848.49M | -2.65% | 619,967 | 82.55M |
| 129 | GERN | Geron Corporation | 843.92M | -3.99% | 3,524,132 | 116.29M |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | 832.81M | -1.33% | 838,715 | 222.55M |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 826.06M | -2.24% | 502,440 | 43.72M |
| 132 | QURE | uniQure N.V. | 794.95M | -2.42% | 260,147 | 20.20M |
| 133 | AVBP | ArriVent BioPharma, Inc. | 792.20M | -1.54% | 52,608 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 785.19M | -4.22% | 510,349 | 20.86M |
| 135 | TRVI | Trevi Therapeutics, Inc. | 775.63M | 1.56% | 543,763 | - |
| 136 | ANAB | AnaptysBio, Inc. | 774.18M | 1.00% | 76,436 | 111.87M |
| 137 | IMNM | Immunome, Inc. | 763.05M | -2.02% | 229,634 | 10.94M |
| 138 | NUVB | Nuvation Bio Inc. | 762.19M | -3.03% | 1,664,132 | 10.96M |
| 139 | IMTX | Immatics N.V. | 729.30M | - | 290,781 | 155.80M |
| 140 | EYPT | EyePoint Pharmaceuticals, Inc. | 723.21M | -4.97% | 339,932 | 56.04M |
| 141 | MRVI | Maravai LifeSciences Holdings, Inc. | 711.77M | -3.29% | 501,988 | 241.86M |
| 142 | DAWN | Day One Biopharmaceuticals, Inc. | 706.50M | -3.06% | 512,405 | 161.92M |
| 143 | PHAR | Pharming Group N.V. | 705.89M | 0.52% | 1,000 | 320.71M |
| 144 | KALV | KalVista Pharmaceuticals, Inc. | 697.66M | -9.61% | 1,296,865 | - |
| 145 | GYRE | Gyre Therapeutics, Inc. | 681.74M | -3.71% | 35,209 | 100.64M |
| 146 | AMLX | Amylyx Pharmaceuticals, Inc. | 679.26M | 3.11% | 559,610 | -1.27M |
| 147 | MGTX | MeiraGTx Holdings plc | 678.69M | -2.03% | 271,147 | 34.51M |
| 148 | ZVRA | Zevra Therapeutics, Inc. | 667.64M | 1.58% | 483,847 | 40.59M |
| 149 | MAZE | Maze Therapeutics, Inc. | 661.83M | -3.38% | 56,213 | 167.50M |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 659.57M | -2.27% | 346,027 | 81.86M |
| 151 | AUTL | Autolus Therapeutics plc | 657.37M | -0.40% | 549,315 | 9.01M |
| 152 | TNGX | Tango Therapeutics, Inc. | 653.62M | -1.31% | 629,592 | 40.99M |
| 153 | STOK | Stoke Therapeutics, Inc. | 653.53M | -0.58% | 200,758 | 190.91M |
| 154 | URGN | UroGen Pharma Ltd. | 651.73M | -3.45% | 301,265 | 91.87M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 650.60M | -1.84% | 72,132 | 6.52M |
| 156 | IOVA | Iovance Biotherapeutics, Inc. | 636.15M | -1.30% | 4,139,618 | 212.68M |
| 157 | XNCR | Xencor, Inc. | 633.42M | -4.09% | 228,660 | 127.23M |
| 158 | UPB | Upstream Bio, Inc. | 624.01M | -2.03% | 58,177 | 2.30M |
| 159 | RLAY | Relay Therapeutics, Inc. | 617.20M | -3.49% | 364,458 | 7.68M |
| 160 | DNA | Ginkgo Bioworks Holdings, Inc. | 600.24M | -4.96% | 885,050 | 237.42M |
| 161 | ABUS | Arbutus Biopharma Corporation | 599.48M | -4.57% | 328,609 | 6.40M |
| 162 | MNMD | Mind Medicine (MindMed) Inc. | 589.32M | -3.70% | 473,861 | - |
| 163 | KROS | Keros Therapeutics, Inc. | 587.71M | - | 146,988 | 214.71M |
| 164 | SAGE | Sage Therapeutics, Inc. | 577.06M | 0.05% | 2,231,876 | 47.40M |
| 165 | ARVN | Arvinas, Inc. | 575.17M | -0.13% | 603,603 | 426.90M |
| 166 | TSHA | Taysha Gene Therapies, Inc. | 573.15M | 4.71% | 1,898,850 | 7.22M |
| 167 | PRME | Prime Medicine, Inc. | 569.95M | -7.25% | 4,320,823 | 3.85M |
| 168 | TBPH | Theravance Biopharma, Inc. | 568.52M | -0.79% | 27,335 | 65.27M |
| 169 | ATAI | Atai Life Sciences N.V. | 565.36M | -2.38% | 1,782,406 | 1.86M |
| 170 | BCYC | Bicycle Therapeutics plc | 556.11M | -0.74% | 95,636 | 25.72M |
| 171 | TYRA | Tyra Biosciences, Inc. | 553.05M | 1.56% | 68,448 | - |
| 172 | KURA | Kura Oncology, Inc. | 548.02M | -0.47% | 569,409 | 67.99M |
| 173 | PGEN | Precigen, Inc. | 538.70M | -4.45% | 700,389 | 4.20M |
| 174 | RAPP | Rapport Therapeutics, Inc. | 534.99M | -4.69% | 58,012 | - |
| 175 | ORKA | Oruka Therapeutics, Inc. | 530.91M | 0.78% | 26,154 | - |
| 176 | SEPN | Septerna, Inc. | 525.79M | 1.03% | 90,871 | 977.00K |
| 177 | ABVX | ABIVAX Société Anonyme | 523.74M | 0.96% | 281,611 | 11.44M |
| 178 | BCAX | Bicara Therapeutics Inc. | 523.55M | -3.23% | 79,824 | - |
| 179 | VALN | Valneva SE | 506.85M | -0.33% | 10,950 | 201.10M |
| 180 | CELC | Celcuity Inc. | 505.52M | -1.98% | 60,248 | - |
| 181 | SVRA | Savara Inc. | 493.01M | 1.74% | 518,257 | - |
| 182 | ZBIO | Zenas BioPharma, Inc. | 482.98M | -4.35% | 34,124 | 15.00M |
| 183 | ATYR | aTyr Pharma, Inc. | 473.50M | -0.19% | 1,702,019 | 235.00K |
| 184 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 185 | FTRE | Fortrea Holdings Inc. | 466.28M | -2.28% | 449,693 | 2.69B |
| 186 | CGEM | Cullinan Therapeutics, Inc. | 456.18M | -1.40% | 62,313 | - |
| 187 | TRML | Tourmaline Bio, Inc. | 454.81M | 1.93% | 36,796 | - |
| 188 | RZLT | Rezolute, Inc. | 450.69M | 0.38% | 159,562 | - |
| 189 | IVA | Inventiva S.A. | 450.35M | 0.60% | 18,705 | 14.59M |
| 190 | RGNX | REGENXBIO Inc. | 442.41M | -3.09% | 130,196 | 156.72M |
| 191 | FULC | Fulcrum Therapeutics, Inc. | 441.01M | 2.00% | 370,100 | 80.00M |
| 192 | MBX | MBX Biosciences, Inc. | 437.86M | 5.65% | 200,089 | - |
| 193 | TERN | Terns Pharmaceuticals, Inc. | 424.90M | -0.10% | 364,170 | - |
| 194 | PRTC | PureTech Health plc | 424.12M | -3.18% | 276 | 4.83M |
| 195 | NKTR | Nektar Therapeutics | 417.47M | -3.86% | 772,124 | 87.25M |
| 196 | ERAS | Erasca, Inc. | 412.18M | -4.28% | 371,903 | - |
| 197 | SLDB | Solid Biosciences Inc. | 409.67M | -2.49% | 322,290 | - |
| 198 | AURA | Aura Biosciences, Inc. | 407.06M | -3.03% | 28,945 | - |
| 199 | LXRX | Lexicon Pharmaceuticals, Inc. | 406.76M | -0.88% | 2,517,468 | 31.21M |
| 200 | TECX | Tectonic Therapeutic, Inc. | 403.70M | -0.46% | 152,624 | - |
| 201 | ITOS | iTeos Therapeutics, Inc. | 392.50M | 0.44% | 390,680 | 35.00M |
| 202 | CTMX | CytomX Therapeutics, Inc. | 385.98M | -5.77% | 1,036,993 | 147.56M |
| 203 | VIGL | Vigil Neuroscience, Inc. | 383.80M | 0.12% | 166,308 | - |
| 204 | ARCT | Arcturus Therapeutics Holdings Inc. | 378.06M | -3.73% | 83,487 | 143.68M |
| 205 | CMPX | Compass Therapeutics, Inc. | 370.60M | -5.96% | 325,213 | 850.00K |
| 206 | CAPR | Capricor Therapeutics, Inc. | 364.29M | -30.09% | 16,675,212 | 17.36M |
| 207 | HUMA | Humacyte, Inc. | 363.75M | -6.57% | 3,128,341 | 517.00K |
| 208 | ATXS | Astria Therapeutics, Inc. | 362.31M | -3.75% | 114,593 | - |
| 209 | ADCT | ADC Therapeutics SA | 361.31M | -2.42% | 218,019 | 75.82M |
| 210 | RNAC | Cartesian Therapeutics, Inc. | 347.53M | -1.11% | 21,733 | 34.17M |
| 211 | BNTC | Benitec Biopharma Inc. | 343.36M | -5.15% | 15,161 | - |
| 212 | PRTA | Prothena Corporation plc | 342.88M | -3.04% | 288,942 | 137.94M |
| 213 | VOR | Vor Biopharma Inc. | 342.39M | 18.61% | 11,594,892 | - |
| 214 | ABSI | Absci Corporation | 341.22M | -2.01% | 1,753,768 | 4.82M |
| 215 | ALT | Altimmune, Inc. | 338.22M | -5.23% | 2,995,787 | 20.00K |
| 216 | RIGL | Rigel Pharmaceuticals, Inc. | 337.79M | -3.57% | 124,417 | 203.08M |
| 217 | HRTX | Heron Therapeutics, Inc. | 333.35M | -1.58% | 339,553 | 148.52M |
| 218 | OCGN | Ocugen, Inc. | 330.00M | -1.74% | 3,142,389 | 4.52M |
| 219 | XOMA | XOMA Royalty Corporation | 328.01M | -1.76% | 30,933 | 42.91M |
| 220 | RCKT | Rocket Pharmaceuticals, Inc. | 326.98M | -3.96% | 875,389 | - |
| 221 | JBIO | Jade Biosciences, Inc. | 325.58M | -3.99% | 57,393 | - |
| 222 | AVIR | Atea Pharmaceuticals, Inc. | 322.63M | -0.26% | 148,137 | - |
| 223 | OLMA | Olema Pharmaceuticals, Inc. | 320.21M | -3.51% | 104,114 | - |
| 224 | CRVS | Corvus Pharmaceuticals, Inc. | 320.03M | -2.35% | 153,692 | - |
| 225 | INBX | Inhibrx Biosciences, Inc. | 319.70M | 5.27% | 14,676 | 200.00K |
| 226 | GLUE | Monte Rosa Therapeutics, Inc. | 318.31M | -1.62% | 109,769 | 159.49M |
| 227 | GOSS | Gossamer Bio, Inc. | 314.81M | 1.84% | 372,695 | 124.59M |
| 228 | NGNE | Neurogene Inc. | 312.77M | -0.14% | 46,561 | 925.00K |
| 229 | SGMT | Sagimet Biosciences Inc. | 311.65M | -2.32% | 637,515 | - |
| 230 | DBVT | DBV Technologies S.A. | 304.94M | -0.31% | 1,325 | 3.50M |
| 231 | SLN | Silence Therapeutics plc | 304.94M | 0.57% | 51,883 | 27.70M |
| 232 | TNXP | Tonix Pharmaceuticals Holding Corp. | 304.75M | -2.86% | 406,533 | 10.04M |
| 233 | FHTX | Foghorn Therapeutics Inc. | 299.33M | -0.56% | 32,791 | 23.50M |
| 234 | CADL | Candel Therapeutics, Inc. | 297.61M | -3.41% | 455,698 | - |
| 235 | ABEO | Abeona Therapeutics Inc. | 293.13M | -2.05% | 337,169 | - |
| 236 | PVLA | Palvella Therapeutics, Inc. | 290.21M | -2.56% | 26,196 | - |
| 237 | ANNX | Annexon, Inc. | 288.00M | -6.25% | 915,291 | - |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 281.71M | -4.21% | 298,880 | 201.35M |
| 239 | ALDX | Aldeyra Therapeutics, Inc. | 280.31M | -2.50% | 1,048,503 | - |
| 240 | ALLO | Allogene Therapeutics, Inc. | 279.98M | 1.59% | 1,886,673 | 22.00K |
| 241 | CRDF | Cardiff Oncology, Inc. | 273.09M | -1.32% | 470,262 | 587.00K |
| 242 | AARD | Aardvark Therapeutics, Inc. | 267.51M | -2.14% | 9,542 | - |
| 243 | DRTS | Alpha Tau Medical Ltd. | 260.87M | -2.23% | 7,740 | - |
| 244 | MREO | Mereo BioPharma Group plc | 258.38M | -3.85% | 5,618,702 | 1.00M |
| 245 | CDXS | Codexis, Inc. | 256.82M | -0.32% | 294,186 | 49.82M |
| 246 | NBTX | Nanobiotix S.A. | 256.80M | 2.87% | 435 | -7.44M |
| 247 | VSTM | Verastem, Inc. | 255.79M | -1.79% | 664,824 | 10.00M |
| 248 | INKT | MiNK Therapeutics, Inc. | 253.09M | 721.47% | 38,102,247 | - |
| 249 | OABI | OmniAb, Inc. | 248.34M | -1.46% | 239,113 | 26.74M |
| 250 | THRD | Third Harmonic Bio, Inc. | 246.40M | 0.18% | 91,190 | - |
| 251 | PRQR | ProQR Therapeutics N.V. | 245.45M | -1.27% | 128,258 | 21.21M |
| 252 | EDIT | Editas Medicine, Inc. | 244.86M | -4.41% | 1,703,192 | 35.84M |
| 253 | FENC | Fennec Pharmaceuticals Inc. | 243.87M | -2.32% | 79,205 | 30.91M |
| 254 | LXEO | Lexeo Therapeutics, Inc. | 242.99M | -1.96% | 70,500 | - |
| 255 | TVRD | Tvardi Therapeutics, Inc. | 240.76M | 13.45% | 50,618 | - |
| 256 | SCPH | scPharmaceuticals Inc. | 238.09M | 0.89% | 180,994 | 41.98M |
| 257 | NVCT | Nuvectis Pharma, Inc. | 237.33M | -2.99% | 20,170 | - |
| 258 | TENX | Tenax Therapeutics, Inc. | 232.00M | 1.24% | 5,524 | - |
| 259 | TRDA | Entrada Therapeutics, Inc. | 231.64M | -2.81% | 85,739 | 172.22M |
| 260 | IMMP | Immutep Limited | 230.04M | 1.83% | 33,746 | 3.02M |
| 261 | KOD | Kodiak Sciences Inc. | 228.94M | -3.12% | 81,534 | - |
| 262 | LCTX | Lineage Cell Therapeutics, Inc. | 227.74M | -2.23% | 638,934 | 9.56M |
| 263 | DSGN | Design Therapeutics, Inc. | 224.24M | -2.23% | 17,236 | - |
| 264 | MDWD | MediWound Ltd. | 223.88M | -1.78% | 10,964 | 19.21M |
| 265 | TVGN | Tevogen Bio Holdings Inc. | 222.25M | -1.23% | 84,207 | - |
| 266 | MNPR | Monopar Therapeutics Inc. | 220.15M | -5.91% | 17,506 | - |
| 267 | LRMR | Larimar Therapeutics, Inc. | 219.62M | -1.44% | 370,906 | - |
| 268 | OMER | Omeros Corporation | 216.79M | 6.94% | 669,234 | - |
| 269 | CRGX | CARGO Therapeutics, Inc. | 213.28M | -0.33% | 686,559 | - |
| 270 | ELDN | Eledon Pharmaceuticals, Inc. | 208.39M | 0.87% | 116,905 | - |
| 271 | ACIU | AC Immune SA | 204.81M | -1.90% | 48,724 | 32.01M |
| 272 | NMRA | Neumora Therapeutics, Inc. | 200.57M | 16.98% | 2,461,503 | - |
| 273 | EPRX | Eupraxia Pharmaceuticals Inc. | 199.87M | -2.56% | 4,106 | - |
| 274 | FDMT | 4D Molecular Therapeutics, Inc. | 199.20M | -1.15% | 76,476 | 23.00K |
| 275 | YMAB | Y-mAbs Therapeutics, Inc. | 196.13M | -4.20% | 52,233 | 88.66M |
| 276 | VTYX | Ventyx Biosciences, Inc. | 195.69M | -3.17% | 528,128 | - |
| 277 | CBIO | Crescent Biopharma, Inc. | 195.00M | -3.41% | 150,191 | - |
| 278 | VYGR | Voyager Therapeutics, Inc. | 194.51M | -0.99% | 510,120 | 66.96M |
| 279 | ALMS | Alumis Inc. | 193.14M | -0.28% | 291,250 | 17.39M |
| 280 | GNFT | Genfit S.A. | 192.99M | -2.27% | 1,117 | 73.19M |
| 281 | AGEN | Agenus Inc. | 191.23M | 17.82% | 4,456,381 | 99.52M |
| 282 | ENGNW | enGene Holdings Inc. | 188.07M | - | 11 | - |
| 283 | SLS | SELLAS Life Sciences Group, Inc. | 183.59M | -2.90% | 1,180,765 | - |
| 284 | DRUG | Bright Minds Biosciences Inc. | 180.95M | -4.55% | 10,715 | - |
| 285 | IMAB | I-Mab | 175.50M | 4.84% | 184,987 | 569.46K |
| 286 | LIMN | Liminatus Pharma, Inc. | 175.44M | -6.34% | 103,605 | - |
| 287 | CYBN | Cybin Inc. | 175.28M | 0.13% | 227,345 | - |
| 288 | ACOG | Alpha Cognition Inc. | 174.14M | -1.18% | 16,456 | 2.93M |
| 289 | PBYI | Puma Biotechnology, Inc. | 171.25M | -1.99% | 133,368 | 232.71M |
| 290 | ENGN | enGene Holdings Inc. | 171.20M | -8.97% | 49,989 | - |
| 291 | ACRS | Aclaris Therapeutics, Inc. | 167.84M | -2.52% | 313,967 | 17.78M |
| 292 | KYTX | Kyverna Therapeutics, Inc. | 166.82M | 8.12% | 535,987 | - |
| 293 | TLSA | Tiziana Life Sciences Ltd | 163.85M | - | 122,438 | - |
| 294 | IPHA | Innate Pharma S.A. | 162.87M | -2.76% | 3,863 | 20.83M |
| 295 | BDTX | Black Diamond Therapeutics, Inc. | 160.92M | 3.28% | 515,266 | 70.00M |
| 296 | TIL | Instil Bio, Inc. | 160.26M | -8.71% | 97,612 | - |
| 297 | ALEC | Alector, Inc. | 160.05M | -6.94% | 113,167 | 88.34M |
| 298 | CABA | Cabaletta Bio, Inc. | 159.20M | 1.72% | 452,360 | - |
| 299 | CCCC | C4 Therapeutics, Inc. | 159.06M | 12.56% | 3,065,422 | 39.78M |
| 300 | GALT | Galectin Therapeutics Inc. | 157.91M | 1.84% | 288,139 | - |
| 301 | SPRO | Spero Therapeutics, Inc. | 157.67M | -0.70% | 511,684 | 44.58M |
| 302 | DMAC | DiaMedica Therapeutics Inc. | 156.85M | -0.34% | 47,462 | - |
| 303 | CRBU | Caribou Biosciences, Inc. | 154.39M | -4.60% | 778,202 | 9.92M |
| 304 | IMRX | Immuneering Corporation | 153.30M | -1.62% | 485,951 | - |
| 305 | CGEN | Compugen Ltd. | 151.49M | -4.14% | 178,892 | 27.59M |
| 306 | LYEL | Lyell Immunopharma, Inc. | 144.82M | 0.10% | 12,094 | 65.00K |
| 307 | THTX | Theratechnologies Inc. | 144.81M | 0.16% | 236,461 | 84.38M |
| 308 | GLSI | Greenwich LifeSciences, Inc. | 144.38M | -3.74% | 34,663 | - |
| 309 | ENTA | Enanta Pharmaceuticals, Inc. | 142.58M | -4.44% | 100,648 | 64.46M |
| 310 | RAPT | RAPT Therapeutics, Inc. | 140.89M | -1.16% | 17,075 | - |
| 311 | ASMB | Assembly Biosciences, Inc. | 140.84M | 1.21% | 22,065 | 32.15M |
| 312 | IKT | Inhibikase Therapeutics, Inc. | 138.28M | -7.00% | 70,568 | 1.00 |
| 313 | MOLN | Molecular Partners AG | 135.29M | 1.97% | 160 | 2.53M |
| 314 | FATE | Fate Therapeutics, Inc. | 131.29M | -1.27% | 591,576 | 13.34M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 129.81M | -1.79% | 16,784 | - |
| 316 | FBRX | Forte Biosciences, Inc. | 127.27M | -9.04% | 64,824 | - |
| 317 | NKTX | Nkarta, Inc. | 126.66M | -0.83% | 520,241 | - |
| 318 | GNLX | Genelux Corporation | 126.45M | -1.45% | 49,227 | 8.00K |
| 319 | SKYE | Skye Bioscience, Inc. | 126.11M | 3.30% | 262,432 | - |
| 320 | VTVT | vTv Therapeutics Inc. | 125.68M | 0.23% | 1,467 | 17.00K |
| 321 | SEER | Seer, Inc. | 125.64M | -2.51% | 40,939 | 15.31M |
| 322 | ATOS | Atossa Therapeutics, Inc. | 121.25M | 5.72% | 805,243 | - |
| 323 | KRRO | Korro Bio, Inc. | 119.73M | -6.18% | 40,468 | 4.82M |
| 324 | ACTU | Actuate Therapeutics, Inc. | 118.70M | -2.10% | 13,395 | - |
| 325 | SGMO | Sangamo Therapeutics, Inc. | 118.02M | -0.66% | 1,661,141 | 63.76M |
| 326 | TARA | Protara Therapeutics, Inc. | 117.67M | -2.24% | 51,260 | - |
| 327 | ACHV | Achieve Life Sciences, Inc. | 116.54M | -2.79% | 198,378 | - |
| 328 | CSBR | Champions Oncology, Inc. | 116.37M | -3.63% | 3,877 | 58.59M |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 113.04M | -4.05% | 685,518 | 59.76M |
| 330 | CLLS | Cellectis S.A. | 112.54M | -1.33% | 3,255 | 54.75M |
| 331 | OBIO | Orchestra BioMed Holdings, Inc. | 112.26M | -2.33% | 76,109 | 2.89M |
| 332 | BMEA | Biomea Fusion, Inc. | 110.91M | 0.78% | 431,076 | - |
| 333 | HURA | TuHURA Biosciences, Inc. | 110.79M | -5.56% | 95,861 | - |
| 334 | TNYA | Tenaya Therapeutics, Inc. | 110.78M | -0.98% | 1,444,605 | - |
| 335 | ONCY | Oncolytics Biotech Inc. | 106.59M | 4.04% | 669,313 | - |
| 336 | VXRT | Vaxart, Inc. | 106.12M | 34.01% | 3,352,969 | 47.40M |
| 337 | MIST | Milestone Pharmaceuticals Inc. | 105.87M | -37.70% | 17,427,605 | - |
| 338 | MCRB | Seres Therapeutics, Inc. | 105.75M | -1.94% | 18,661 | - |
| 339 | OKYO | OKYO Pharma Limited | 104.04M | -2.80% | 67,024 | - |
| 340 | TCRX | TScan Therapeutics, Inc. | 103.84M | -0.27% | 176,868 | 4.42M |
| 341 | HLVX | HilleVax, Inc. | 103.43M | -0.71% | 52,183 | - |
| 342 | COYA | Coya Therapeutics, Inc. | 102.52M | -3.08% | 44,303 | 3.69M |
| 343 | SAVA | Cassava Sciences, Inc. | 102.41M | -1.85% | 254,203 | - |
| 344 | CHRS | Coherus Oncology, Inc. | 102.02M | 1.48% | 1,129,174 | 272.25M |
| 345 | CTNM | Contineum Therapeutics, Inc. | 101.80M | -2.36% | 28,788 | - |
| 346 | MGNX | MacroGenics, Inc. | 101.58M | 1.90% | 490,473 | 154.05M |
| 347 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 101.57M | -0.72% | 44,772 | - |
| 348 | ANIX | Anixa Biosciences, Inc. | 101.46M | 0.32% | 81,032 | - |
| 349 | NAUT | Nautilus Biotechnology, Inc. | 96.33M | 1.54% | 176,730 | - |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 95.13M | 2.46% | 106,940 | 79.99K |
| 351 | ZNTL | Zentalis Pharmaceuticals, Inc. | 94.98M | -3.65% | 469,478 | 26.87M |
| 352 | ADAG | Adagene Inc. | 93.75M | 2.58% | 17,599 | 103.20K |
| 353 | BYSI | BeyondSpring Inc. | 93.13M | 2.67% | 480 | 1.88M |
| 354 | CLYM | Climb Bio, Inc. | 92.58M | 1.48% | 87,758 | - |
| 355 | WHWK | Whitehawk Therapeutics, Inc. | 91.63M | -1.27% | 96,816 | 27.78M |
| 356 | IOBT | IO Biotech, Inc. | 90.26M | -2.14% | 224,217 | - |
| 357 | ATHE | Alterity Therapeutics Limited | 89.86M | 19.02% | 576,731 | 2.30M |
| 358 | NTRB | Nutriband Inc. | 89.54M | -1.89% | 31,386 | 2.40M |
| 359 | XBIT | XBiotech Inc. | 89.03M | -1.34% | 30,620 | - |
| 360 | IVVD | Invivyd, Inc. | 88.35M | -1.19% | 224,174 | 36.69M |
| 361 | OTLK | Outlook Therapeutics, Inc. | 87.64M | 1.24% | 1,024,755 | - |
| 362 | VERU | Veru Inc. | 87.55M | 2.42% | 1,204,367 | 16.89M |
| 363 | ORMP | Oramed Pharmaceuticals Inc. | 87.01M | 0.47% | 12,115 | 2.00M |
| 364 | QNCX | Quince Therapeutics, Inc. | 86.85M | 7.30% | 434,981 | - |
| 365 | CNTB | Connect Biopharma Holdings Limited | 86.12M | 34.78% | 520,034 | 26.03M |
| 366 | PLRX | Pliant Therapeutics, Inc. | 85.33M | -0.71% | 383,330 | - |
| 367 | ABOS | Acumen Pharmaceuticals, Inc. | 84.80M | 7.69% | 595,964 | - |
| 368 | JUNS | Jupiter Neurosciences, Inc. | 84.58M | 33.77% | 1,104,405 | - |
| 369 | EXOZ | eXoZymes, Inc. | 83.89M | 0.05% | 3 | -700.00 |
| 370 | ENTX | Entera Bio Ltd. | 83.59M | -0.05% | 10,290 | 223.00K |
| 371 | ARMP | Armata Pharmaceuticals, Inc. | 82.88M | 0.88% | 1,533 | 4.70M |
| 372 | ZURA | Zura Bio Limited | 82.29M | -4.32% | 140,387 | - |
| 373 | VANI | Vivani Medical, Inc. | 82.05M | 9.06% | 217,921 | - |
| 374 | IGMS | IGM Biosciences, Inc. | 81.26M | -0.74% | 117,723 | 2.68M |
| 375 | MGX | Metagenomi, Inc. | 80.37M | -2.71% | 489,075 | 45.26M |
| 376 | IMUX | Immunic, Inc. | 80.08M | -0.24% | 314,426 | - |
| 377 | CBUS | Cibus, Inc. | 79.91M | 0.31% | 175,676 | 4.75M |
| 378 | EPIX | ESSA Pharma Inc. | 76.35M | -1.71% | 20,330 | - |
| 379 | IMMX | Immix Biopharma, Inc. | 75.48M | - | 217,868 | - |
| 380 | SRZN | Surrozen, Inc. | 74.58M | 1.63% | 190 | 11.64M |
| 381 | GUTS | Fractyl Health, Inc. | 73.95M | -0.66% | 73,769 | 60.00K |
| 382 | VRCA | Verrica Pharmaceuticals Inc. | 73.49M | -8.93% | 303,787 | 7.18M |
| 383 | PYXS | Pyxis Oncology, Inc. | 72.44M | -1.74% | 122,318 | 16.15M |
| 384 | KLTO | Klotho Neurosciences, Inc. | 71.68M | -6.85% | 4,762,067 | - |
| 385 | ADAP | Adaptimmune Therapeutics plc | 71.44M | -1.73% | 251,182 | 179.64M |
| 386 | GNTA | Genenta Science S.p.A. | 71.18M | -0.21% | 3,130 | - |
| 387 | INO | Inovio Pharmaceuticals, Inc. | 69.81M | -1.44% | 1,164,839 | 283.10K |
| 388 | ANEB | Anebulo Pharmaceuticals, Inc. | 69.23M | -4.80% | 216 | - |
| 389 | ANRO | Alto Neuroscience, Inc. | 69.03M | -1.16% | 38,679 | - |
| 390 | VTGN | Vistagen Therapeutics, Inc. | 68.52M | -3.29% | 141,498 | 486.00K |
| 391 | IPA | ImmunoPrecise Antibodies Ltd. | 67.73M | -11.11% | 1,269,312 | 16.58M |
| 392 | CLSD | Clearside Biomedical, Inc. | 66.60M | -2.11% | 53,297 | 3.76M |
| 393 | IRD | Opus Genetics, Inc. | 66.22M | -0.89% | 117,848 | 13.65M |
| 394 | IKNA | Ikena Oncology, Inc. | 65.63M | -2.16% | 23,832 | - |
| 395 | STRO | Sutro Biopharma, Inc. | 65.17M | -5.65% | 64,043 | 66.43M |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 64.94M | -1.57% | 44,813 | - |
| 397 | RPTX | Repare Therapeutics Inc. | 64.77M | -3.21% | 51,281 | 1.07M |
| 398 | QNTM | Quantum BioPharma Ltd. | 64.40M | -3.81% | 100,625 | - |
| 399 | ACET | Adicet Bio, Inc. | 62.86M | 2.73% | 302,863 | - |
| 400 | UNCY | Unicycive Therapeutics, Inc. | 62.76M | -5.43% | 457,366 | - |
| 401 | MNOV | MediciNova, Inc. | 62.04M | -0.39% | 13,066 | - |
| 402 | INMB | INmune Bio, Inc. | 61.68M | 4.04% | 909,614 | 50.00K |
| 403 | ABVC | ABVC BioPharma, Inc. | 61.40M | 12.78% | 956,640 | 508.38K |
| 404 | CNTX | Context Therapeutics Inc. | 61.00M | 1.48% | 37,295 | - |
| 405 | CRVO | CervoMed Inc. | 60.05M | -4.30% | 97,912 | 9.31M |
| 406 | IFRX | InflaRx N.V. | 59.62M | -1.69% | 145,888 | 140.24K |
| 407 | SNTI | Senti Biosciences, Inc. | 58.94M | -2.59% | 27,873 | - |
| 408 | APLT | Applied Therapeutics, Inc. | 58.81M | 0.31% | 847,615 | 265.00K |
| 409 | SER | Serina Therapeutics, Inc. | 58.51M | -0.44% | 1,751 | 51.00K |
| 410 | ICCC | ImmuCell Corporation | 57.75M | -1.99% | 1,539 | 27.30M |
| 411 | PDSB | PDS Biotechnology Corporation | 57.14M | -3.85% | 267,599 | - |
| 412 | ANL | Adlai Nortye Ltd. | 56.83M | 1.99% | 225 | 1.94M |
| 413 | MAIA | MAIA Biotechnology, Inc. | 56.77M | -2.94% | 155,379 | - |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 56.36M | -0.31% | 97,863 | - |
| 415 | FBIO | Fortress Biotech, Inc. | 55.30M | -6.03% | 356,368 | 57.78M |
| 416 | ATRA | Atara Biotherapeutics, Inc. | 54.87M | -2.90% | 13,818 | 199.73M |
| 417 | ANVS | Annovis Bio, Inc. | 54.76M | -1.40% | 177,367 | - |
| 418 | HOWL | Werewolf Therapeutics, Inc. | 54.75M | 12.96% | 470,529 | 1.14M |
| 419 | CUE | Cue Biopharma, Inc. | 54.33M | -9.42% | 154,394 | 7.99M |
| 420 | IPSC | Century Therapeutics, Inc. | 53.59M | 0.61% | 477,110 | 114.90M |
| 421 | AVTX | Avalo Therapeutics, Inc. | 53.00M | -0.10% | 25,671 | 441.00K |
| 422 | ADVM | Adverum Biotechnologies, Inc. | 52.54M | -7.54% | 39,484 | 1.00M |
| 423 | JSPR | Jasper Therapeutics, Inc. | 52.43M | -1.69% | 369,495 | - |
| 424 | ALGS | Aligos Therapeutics, Inc. | 51.95M | -3.36% | 40,507 | 3.27M |
| 425 | CELU | Celularity Inc. | 51.49M | -0.47% | 54,196 | 54.22M |
| 426 | GANX | Gain Therapeutics, Inc. | 51.43M | -1.69% | 130,866 | - |
| 427 | OSTX | OS Therapies Incorporated | 50.15M | 1.20% | 269,356 | - |
| 428 | NRSN | NeuroSense Therapeutics Ltd. | 50.14M | -0.95% | 123,599 | - |
| 429 | DTIL | Precision BioSciences, Inc. | 49.34M | -7.87% | 123,566 | 51.14M |
| 430 | RNXT | RenovoRx, Inc. | 48.64M | -0.75% | 48,813 | 240.00K |
| 431 | ARTV | Artiva Biotherapeutics, Inc. | 47.75M | 9.50% | 517,483 | 251.00K |
| 432 | ATNM | Actinium Pharmaceuticals, Inc. | 47.11M | -2.58% | 126,789 | 81.00K |
| 433 | RENB | Renovaro Inc. | 47.02M | -8.08% | 995,057 | - |
| 434 | PRLD | Prelude Therapeutics Incorporated | 46.86M | -6.44% | 94,645 | 7.00M |
| 435 | KLRS | Kalaris Therapeutics, Inc. | 46.76M | - | 21,311 | - |
| 436 | ITRM | Iterum Therapeutics plc | 46.60M | 7.87% | 1,369,261 | - |
| 437 | XCUR | Exicure, Inc. | 45.88M | -0.24% | 7,075 | 500.00K |
| 438 | GRCE | Grace Therapeutics, Inc. | 43.56M | 1.61% | 50,359 | - |
| 439 | MRSN | Mersana Therapeutics, Inc. | 43.27M | -8.63% | 2,193,604 | 34.01M |
| 440 | PLUR | Pluri Inc. | 42.43M | -0.37% | 1,456 | 1.03M |
| 441 | BRNS | Barinthus Biotherapeutics plc | 42.36M | -0.94% | 3,427 | 14.97M |
| 442 | MURA | Mural Oncology plc | 42.14M | -1.81% | 27,080 | - |
| 443 | ACRV | Acrivon Therapeutics, Inc. | 41.70M | -1.48% | 64,981 | - |
| 444 | PEPG | PepGen Inc. | 40.90M | - | 126,562 | - |
| 445 | KALA | KALA BIO, Inc. | 38.39M | -13.77% | 102,700 | - |
| 446 | XLO | Xilio Therapeutics, Inc. | 38.38M | -0.38% | 196,221 | 9.27M |
| 447 | LTRN | Lantern Pharma Inc. | 38.29M | 1.14% | 151,282 | - |
| 448 | RANI | Rani Therapeutics Holdings, Inc. | 37.92M | -0.20% | 456,677 | 1.20M |
| 449 | CGTX | Cognition Therapeutics, Inc. | 37.35M | -13.89% | 6,502,071 | - |
| 450 | STTK | Shattuck Labs, Inc. | 37.33M | 0.65% | 91,766 | 4.61M |
| 451 | LVTX | LAVA Therapeutics N.V. | 35.91M | 1.10% | 3,277 | 4.99M |
| 452 | AKTX | Akari Therapeutics, Plc | 35.72M | -3.06% | 12,300 | - |
| 453 | PYPD | PolyPid Ltd. | 34.85M | -1.44% | 54,295 | - |
| 454 | OKUR | OnKure Therapeutics, Inc. | 34.72M | 0.78% | 54,307 | - |
| 455 | TELO | Telomir Pharmaceuticals, Inc. | 34.52M | -0.85% | 127,626 | - |
| 456 | RADX | Radiopharm Theranostics Limited | 34.15M | 2.02% | 11,710 | 204.61K |
| 457 | KZR | Kezar Life Sciences, Inc. | 34.12M | -2.51% | 82 | - |
| 458 | RNTX | Rein Therapeutics Inc. | 33.44M | 1.99% | 4,258 | - |
| 459 | KPTI | Karyopharm Therapeutics Inc. | 33.09M | -23.40% | 804,331 | 142.13M |
| 460 | COEP | Coeptis Therapeutics Holdings, Inc. | 32.72M | -1.98% | 13,541 | 62.87K |
| 461 | IGC | IGC Pharma, Inc. | 32.30M | -7.23% | 4,946,650 | 1.27M |
| 462 | ANTX | AN2 Therapeutics, Inc. | 31.84M | -1.40% | 24,201 | - |
| 463 | QTTB | Q32 Bio Inc. | 31.35M | -22.59% | 3,521,813 | - |
| 464 | ESLA | Estrella Immunopharma, Inc. | 31.16M | -6.75% | 2,139 | - |
| 465 | CAMP | Camp4 Therapeutics Corporation | 30.44M | -1.95% | 18,298 | 1.51M |
| 466 | ENLV | Enlivex Therapeutics Ltd. | 30.32M | -4.48% | 53,693 | - |
| 467 | DYAI | Dyadic International, Inc. | 29.76M | -1.10% | 16,022 | 3.55M |
| 468 | FGEN | FibroGen, Inc. | 29.18M | -1.77% | 47,684 | 7.00M |
| 469 | OVID | Ovid Therapeutics Inc. | 29.15M | -2.15% | 451,109 | 548.00K |
| 470 | TPST | Tempest Therapeutics, Inc. | 28.86M | -4.08% | 53,394 | - |
| 471 | CALC | CalciMedica, Inc. | 28.36M | 25.31% | 206,489 | - |
| 472 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 27.10M | 1.66% | 2,093,912 | - |
| 473 | PBM | Psyence Biomedical Ltd. | 27.09M | 2.22% | 4,472 | - |
| 474 | BOLD | Boundless Bio, Inc. | 26.41M | - | 52,765 | - |
| 475 | CLDI | Calidi Biotherapeutics, Inc. | 26.20M | -21.84% | 9,620,888 | - |
| 476 | GBIO | Generation Bio Co. | 26.15M | 4.61% | 796,289 | 24.56M |
| 477 | PASG | Passage Bio, Inc. | 25.92M | 4.93% | 270,783 | - |
| 478 | ALXO | ALX Oncology Holdings Inc. | 25.81M | -2.82% | 134,897 | - |
| 479 | GDTC | CytoMed Therapeutics Limited | 25.50M | 0.45% | 1,045 | 368.84K |
| 480 | CVKD | Cadrenal Therapeutics, Inc. | 25.21M | -1.38% | 21,497 | - |
| 481 | SABS | SAB Biotherapeutics, Inc. | 24.98M | 7.52% | 39,660 | 377.84K |
| 482 | FBLG | FibroBiologics, Inc. | 24.72M | -2.93% | 174,664 | - |
| 483 | NRXS | NeurAxis, Inc. | 23.44M | 2.07% | 63,890 | 2.93M |
| 484 | LSTA | Lisata Therapeutics, Inc. | 23.39M | -0.73% | 7,129 | 1.00M |
| 485 | PULM | Pulmatrix, Inc. | 23.28M | -1.01% | 2,382 | 1.92M |
| 486 | DARE | Daré Bioscience, Inc. | 23.19M | 9.62% | 7,893,394 | 25.91K |
| 487 | OSRH | OSR Holdings, Inc. | 23.13M | -0.83% | 98,740 | -148.95K |
| 488 | SLGL | Sol-Gel Technologies Ltd. | 22.69M | 0.43% | 2,129 | 12.10M |
| 489 | VYNE | VYNE Therapeutics Inc. | 22.66M | -1.45% | 326,242 | 605.00K |
| 490 | LGVN | Longeveron Inc. | 22.53M | 0.07% | 374,182 | 2.23M |
| 491 | PTIX | Protagenic Therapeutics, Inc. | 22.51M | -2.40% | 193,542 | - |
| 492 | CMMB | Chemomab Therapeutics Ltd. | 22.42M | 0.86% | 56,433 | - |
| 493 | NNVC | NanoViricides, Inc. | 22.38M | -1.26% | 92,071 | - |
| 494 | BCAB | BioAtla, Inc. | 22.37M | -0.96% | 628,540 | 11.00M |
| 495 | ELEV | Elevation Oncology, Inc. | 22.22M | -0.95% | 283,925 | - |
| 496 | RLMD | Relmada Therapeutics, Inc. | 21.90M | -1.52% | 38,923 | - |
| 497 | MLEC | Moolec Science SA | 21.39M | -7.63% | 17,042 | 7.83M |
| 498 | CASI | CASI Pharmaceuticals, Inc. | 21.07M | -4.89% | 14,106 | 31.37M |
| 499 | LSB | LakeShore Biopharma Co., Ltd | 20.61M | 0.93% | 107,863 | 79.42M |
| 500 | APUS | Apimeds Pharmaceuticals US, Inc. | 20.26M | -3.31% | 11,280 | - |
| 501 | BLRX | BioLineRx Ltd. | 20.05M | -3.69% | 36,303 | 22.34M |
| 502 | CRIS | Curis, Inc. | 19.88M | -1.55% | 665,707 | 11.20M |
| 503 | HOTH | Hoth Therapeutics, Inc. | 19.02M | -3.36% | 392,825 | - |
| 504 | CVM | CEL-SCI Corporation | 18.95M | -3.40% | 25,448,052 | - |
| 505 | CING | Cingulate Inc. | 18.81M | - | 67,416 | - |
| 506 | MRKR | Marker Therapeutics, Inc. | 18.44M | -9.44% | 109,726 | 5.70M |
| 507 | CLGN | CollPlant Biotechnologies Ltd. | 18.06M | 0.71% | 27,832 | 2.47M |
| 508 | MEIP | MEI Pharma, Inc. | 17.92M | - | 10,017 | - |
| 509 | CTXR | Citius Pharmaceuticals, Inc. | 17.77M | -2.45% | 307,900 | - |
| 510 | PSTV | Plus Therapeutics, Inc. | 17.67M | -1.28% | 4,791,152 | 5.21M |
| 511 | LPCN | Lipocine Inc. | 17.60M | -0.92% | 24,268 | 3.67M |
| 512 | ARTL | Artelo Biosciences, Inc. | 17.27M | -11.40% | 141,584 | - |
| 513 | ATHA | Athira Pharma, Inc. | 17.13M | 4.22% | 196,416 | - |
| 514 | COCP | Cocrystal Pharma, Inc. | 17.09M | 7.01% | 109,159 | - |
| 515 | LEXX | Lexaria Bioscience Corp. | 16.95M | -3.33% | 88,464 | 525.92K |
| 516 | CARM | Carisma Therapeutics, Inc. | 16.58M | -0.33% | 478,111 | 19.96M |
| 517 | ASBP | Aspire Biopharma Holdings, Inc. | 16.47M | -2.71% | 1,129,383 | - |
| 518 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 16.46M | -1.52% | 461,641 | 1.00M |
| 519 | RLYB | Rallybio Corporation | 16.40M | -0.45% | 512,744 | 848.00K |
| 520 | EVAX | Evaxion A/S | 16.39M | 0.57% | 333,441 | 3.29M |
| 521 | CANF | Can-Fite BioPharma Ltd. | 15.62M | -0.48% | 28,903 | 674.00K |
| 522 | GOVX | GeoVax Labs, Inc. | 15.46M | 0.46% | 1,496,825 | 5.59M |
| 523 | HOOK | HOOKIPA Pharma Inc. | 15.21M | -2.43% | 30,510 | 9.35M |
| 524 | EDSA | Edesa Biotech, Inc. | 14.89M | 2.42% | 13,864 | - |
| 525 | ALLR | Allarity Therapeutics, Inc. | 14.87M | -8.70% | 259,812 | - |
| 526 | ERNA | Ernexa Therapeutics Inc. | 14.58M | - | 4,769 | 535.00K |
| 527 | NEUP | Neuphoria Therapeutics Inc. | 14.48M | 1.32% | 23,961 | 15.66M |
| 528 | SYBX | Synlogic, Inc. | 14.26M | -1.68% | 961 | 8.00K |
| 529 | LPTX | Leap Therapeutics, Inc. | 14.17M | -3.72% | 143,636 | - |
| 530 | MTVA | MetaVia Inc. | 14.01M | -0.40% | 26,687 | - |
| 531 | LYRA | Lyra Therapeutics, Inc. | 13.91M | -3.97% | 27,425 | 1.19M |
| 532 | BCTX | BriaCell Therapeutics Corp. | 13.86M | -0.48% | 1,036,843 | - |
| 533 | PRTG | Portage Biotech Inc. | 13.48M | -3.32% | 7,137 | - |
| 534 | IMNN | Imunon, Inc. | 13.45M | -2.88% | 507,153 | - |
| 535 | BIVI | BioVie Inc. | 13.29M | - | 41,912 | - |
| 536 | XTLB | XTL Biopharmaceuticals Ltd. | 13.29M | - | 7,165 | 451.00K |
| 537 | MBRX | Moleculin Biotech, Inc. | 13.16M | 2.25% | 2,005,221 | - |
| 538 | IBIO | iBio, Inc. | 13.13M | -1.84% | 280,347 | 375.00K |
| 539 | PMN | ProMIS Neurosciences, Inc. | 13.08M | -0.62% | 66,849 | - |
| 540 | ABP | Abpro Holdings, Inc. | 12.75M | 7.76% | 2,081,485 | 183.00K |
| 541 | EQ | Equillium, Inc. | 12.66M | 1.78% | 168,301 | 30.41M |
| 542 | EVGN | Evogene Ltd. | 12.58M | -4.83% | 52,540 | 6.77M |
| 543 | TAOX | TAO Synergies Inc. | 12.39M | 11.53% | 848,779 | - |
| 544 | BCDA | BioCardia, Inc. | 12.27M | -2.07% | 92,936 | 3.00K |
| 545 | BRTX | BioRestorative Therapies, Inc. | 12.27M | 2.19% | 9,550 | 391.00K |
| 546 | PTHS | Pelthos Therapeutics Inc. | 12.22M | -30.02% | 141,862 | - |
| 547 | NXTC | NextCure, Inc. | 12.16M | -7.39% | 163,688 | - |
| 548 | BCLI | Brainstorm Cell Therapeutics Inc. | 12.00M | - | 172,341 | - |
| 549 | BOLT | Bolt Biotherapeutics, Inc. | 11.98M | -1.11% | 12,917 | 3.64M |
| 550 | MBIO | Mustang Bio, Inc. | 11.90M | 1.49% | 1,222,626 | - |
| 551 | KAPA | Kairos Pharma, Ltd. | 11.81M | -1.41% | 199,568 | - |
| 552 | BTAI | BioXcel Therapeutics, Inc. | 11.81M | -2.50% | 103,309 | 1.85M |
| 553 | NERV | Minerva Neurosciences, Inc. | 11.75M | 2.44% | 2,149 | - |
| 554 | KZIA | Kazia Therapeutics Limited | 11.72M | 1.16% | 72,696 | 1.55M |
| 555 | CYCN | Cyclerion Therapeutics, Inc. | 11.62M | 1.97% | 43,860 | 2.08M |
| 556 | PHIO | Phio Pharmaceuticals Corp. | 11.42M | -2.66% | 100,195 | - |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 11.20M | -4.41% | 252,052 | - |
| 558 | APVO | Aptevo Therapeutics Inc. | 11.08M | -0.66% | 78,126 | - |
| 559 | PHGE | BiomX Inc. | 10.99M | 2.44% | 38,835 | - |
| 560 | CSCI | COSCIENS Biopharma Inc. | 10.99M | 0.57% | 2,523 | 9.03M |
| 561 | LIXT | Lixte Biotechnology Holdings, Inc. | 10.78M | -7.35% | 630,100 | - |
| 562 | SNSE | Sensei Biotherapeutics, Inc. | 10.73M | -6.48% | 1,975 | - |
| 563 | IMRN | Immuron Limited | 10.60M | 0.85% | 3,575 | 4.05M |
| 564 | ICU | SeaStar Medical Holding Corporation | 9.84M | -0.64% | 2,336,292 | 428.00K |
| 565 | AEON | AEON Biopharma, Inc. | 9.72M | - | 71,150 | - |
| 566 | TCRT | Alaunos Therapeutics, Inc. | 9.63M | -1.28% | 4,069 | 11.00K |
| 567 | KPRX | Kiora Pharmaceuticals, Inc. | 9.44M | 2.99% | 53,934 | 20.00K |
| 568 | APRE | Aprea Therapeutics, Inc. | 9.26M | -5.47% | 51,034 | 1.28M |
| 569 | DWTX | Dogwood Therapeutics, Inc. | 9.25M | -3.01% | 11,206 | - |
| 570 | CLRB | Cellectar Biosciences, Inc. | 8.90M | -0.41% | 45,331 | - |
| 571 | TSBX | Turnstone Biologics Corp. | 8.52M | -0.14% | 57,788 | - |
| 572 | XFOR | X4 Pharmaceuticals, Inc. | 8.51M | -6.37% | 330,443 | 31.36M |
| 573 | TRAW | Traws Pharma, Inc. | 8.48M | -2.97% | 91,114 | 227.00K |
| 574 | INTS | Intensity Therapeutics, Inc. | 8.30M | 4.68% | 5,656,600 | - |
| 575 | GNPX | Genprex, Inc. | 7.99M | -5.29% | 382,589 | - |
| 576 | PMCB | PharmaCyte Biotech, Inc. | 7.71M | 2.41% | 12,504 | - |
| 577 | INAB | IN8bio, Inc. | 7.68M | -2.62% | 102,563 | - |
| 578 | CELZ | Creative Medical Technology Holdings, Inc. | 7.68M | 3.66% | 770,149 | 14.00K |
| 579 | ADXN | Addex Therapeutics Ltd | 7.62M | -1.23% | 1,215 | 278.51K |
| 580 | THAR | Tharimmune, Inc. | 7.50M | 0.56% | 11,459 | - |
| 581 | GTBP | GT Biopharma, Inc. | 7.15M | -0.87% | 59,567 | - |
| 582 | RNAZ | TransCode Therapeutics, Inc. | 7.13M | -4.94% | 15,934 | - |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.09M | -4.90% | 8,094 | 19.90K |
| 584 | IBO | Impact BioMedical Inc. | 6.95M | 0.38% | 257,410 | - |
| 585 | INDP | Indaptus Therapeutics, Inc. | 6.94M | -1.78% | 11,220 | - |
| 586 | PPBT | Purple Biotech Ltd | 6.85M | -4.76% | 6,064 | - |
| 587 | APM | Aptorum Group Limited | 6.72M | 1.08% | 23,379 | - |
| 588 | NLSP | NLS Pharmaceutics AG | 6.67M | -5.82% | 103,745 | - |
| 589 | SLXN | Silexion Therapeutics Corp | 6.61M | -4.94% | 254,848 | - |
| 590 | PCSA | Processa Pharmaceuticals, Inc. | 6.23M | 3.52% | 4,171,146 | - |
| 591 | CYCC | Cyclacel Pharmaceuticals, Inc. | 5.91M | -11.19% | 46,432 | 14.00K |
| 592 | XBIO | Xenetic Biosciences, Inc. | 5.91M | -0.05% | 21,328 | 2.58M |
| 593 | ADIL | Adial Pharmaceuticals, Inc. | 5.90M | -8.71% | 1,421,026 | - |
| 594 | APLM | Apollomics, Inc. | 5.88M | -6.46% | 11,647 | 198.00K |
| 595 | QLGN | Qualigen Therapeutics, Inc. | 5.79M | 0.57% | 40,052 | - |
| 596 | CDT | Conduit Pharmaceuticals Inc. | 5.75M | -0.83% | 99,468 | - |
| 597 | HCWB | HCW Biologics Inc. | 5.74M | -1.70% | 12,125 | 1.45M |
| 598 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.30M | - | 539 | - |
| 599 | ATNF | 180 Life Sciences Corp. | 5.10M | 1.21% | 30,348 | - |
| 600 | CMND | Clearmind Medicine Inc. | 5.10M | 1.33% | 115,845 | - |
| 601 | MTNB | Matinas BioPharma Holdings, Inc. | 5.09M | -2.91% | 56,051 | - |
| 602 | KTTA | Pasithea Therapeutics Corp. | 5.08M | -1.27% | 37,874 | - |
| 603 | TTNP | Titan Pharmaceuticals, Inc. | 5.03M | -2.07% | 8,308 | - |
| 604 | VIVS | VivoSim Labs, Inc. | 5.00M | -2.28% | 18,895 | 144.00K |
| 605 | CNSP | CNS Pharmaceuticals, Inc. | 4.79M | -3.44% | 145,553 | - |
| 606 | GLTO | Galecto, Inc. | 4.77M | 4.03% | 48,303 | - |
| 607 | SILO | Silo Pharma, Inc. | 4.67M | 3.04% | 595,405 | 72.10K |
| 608 | TOVX | Theriva Biologics, Inc. | 4.53M | 6.30% | 300,664 | - |
| 609 | DRMA | Dermata Therapeutics, Inc. | 4.52M | -1.42% | 147,898 | - |
| 610 | GLMD | Galmed Pharmaceuticals Ltd. | 4.31M | -5.91% | 261,659 | - |
| 611 | SNGX | Soligenix, Inc. | 4.18M | 0.79% | 89,304 | 2.34K |
| 612 | NBY | NovaBay Pharmaceuticals, Inc. | 4.02M | 6.27% | 82,242 | 9.78M |
| 613 | AZTR | Azitra, Inc. | 3.98M | -8.47% | 465,361 | 7.50K |
| 614 | VRAX | Virax Biolabs Group Limited | 3.95M | 2.25% | 204,585 | 6.33K |
| 615 | GRI | GRI Bio, Inc. | 3.94M | 6.33% | 69,607 | - |
| 616 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.87M | 0.57% | 32,874 | 802.32K |
| 617 | PLRZ | Polyrizon Ltd. | 3.80M | -0.49% | 75,869 | - |
| 618 | SPRC | SciSparc Ltd. | 3.77M | 2.17% | 6,886 | 1.31M |
| 619 | PALI | Palisade Bio, Inc. | 3.74M | - | 90,389 | - |
| 620 | JAGX | Jaguar Health, Inc. | 3.63M | 4.18% | 141,007 | 11.55M |
| 621 | ENSC | Ensysce Biosciences, Inc. | 3.50M | 1.67% | 181,875 | 6.22M |
| 622 | CERO | CERo Therapeutics Holdings, Inc. | 3.37M | -1.36% | 47,686 | - |
| 623 | ENVB | Enveric Biosciences, Inc. | 3.24M | -2.96% | 47,785 | - |
| 624 | XRTX | XORTX Therapeutics Inc. | 3.15M | 6.90% | 44,433 | - |
| 625 | ELAB | PMGC Holdings Inc. | 3.06M | -1.98% | 23,414 | 2.45M |
| 626 | ZVSA | ZyVersa Therapeutics, Inc. | 2.79M | -2.95% | 886,007 | - |
| 627 | ADTX | Aditxt, Inc. | 2.54M | -1.64% | 192,152 | 55.32K |
| 628 | BDRX | Biodexa Pharmaceuticals Plc | 2.51M | -2.19% | 99,659 | 104.90K |
| 629 | WINT | Windtree Therapeutics, Inc. | 2.51M | 5.34% | 1,881,340 | - |
| 630 | ALZN | Alzamend Neuro, Inc. | 2.41M | 7.54% | 348,075 | - |
| 631 | ENTO | Entero Therapeutics, Inc. | 2.34M | 0.66% | 237,863 | - |
| 632 | ONCO | Onconetix, Inc. | 2.25M | -1.14% | 57,449 | 1.93M |
| 633 | SCNI | Scinai Immunotherapeutics Ltd. | 2.09M | -2.61% | 25,939 | 658.00K |
| 634 | REVB | Revelation Biosciences, Inc. | 1.89M | -0.88% | 119,888 | - |
| 635 | UBX | Unity Biotechnology, Inc. | 1.74M | -36.88% | 1,010,722 | - |
| 636 | TNFA | TNF Pharmaceuticals, Inc. | 1.52M | -8.29% | 3,991,049 | - |
| 637 | SLRX | Salarius Pharmaceuticals, Inc. | 1.51M | -8.86% | 124,222 | - |
| 638 | OGEN | Oragenics, Inc. | 1.14M | -4.76% | 240,092 | - |
| 639 | NCNA | NuCana plc | 309.51K | -14.41% | 173,331,759 | - |